Tag: Connecticut Comptroller Kevin Lembo
Prescription program aims to lower insulin costs for Connecticut residents
Certain forms of Novo Nordisk insulin will be available at 50% less than the retail cost.
CT Comptroller Lembo projects FY2021 deficit of $615.2M
Lembo credited the state's housing market for helping the local economy.